MMS — Maximus, Inc. Stock Price, Chart & AI Report

Positive Apr 3, 2026 • 17:40 UTC GlobeNewswire Inc. • Not Specified

Maximus Ranked #7 on the Financial Times’ List of The Americas’ Fastest Growing Companies 2026

Maximus, a performance medicine telehealth company, has been ranked #7 on the Financial Times' list of The Americas' Fastest Growing Companies 2026, based on compound annual revenue growth between 2021-2024. The company, founded in 2020, offers online treatments including testosterone optimization, GLP-1 weight loss, and peptide therapies, and is backed by Founders Fund and 8VC.

MMS telehealth performance medicine fastest growing companies testosterone optimization GLP-1 weight loss peptide therapies venture capital

Sentiment note

Company achieved #7 ranking among fastest-growing companies in the Americas with strong revenue growth from 2021-2024, expanded treatment offerings, demonstrated market demand, and backing from prominent venture capital firms (Founders Fund and 8VC). Recognition validates business model and market opportunity.

Positive Nov 7, 2025 • 20:56 UTC GlobeNewswire Inc. • Dr. Cameron Sepah

Maximus Announces First-Ever Topical Oxytocin Cream for Mood Enhancement and Sleep Support

Maximus has developed a groundbreaking topical oxytocin cream that provides sustained hormone release for up to 12-16 hours through a novel transdermal delivery technology, addressing previous challenges in maintaining therapeutic oxytocin levels.

MMS oxytocin performance medicine transdermal delivery hormone therapy wellness

Sentiment note

The company demonstrated scientific innovation by solving a complex hormone delivery challenge, developing a patent-pending technology with significant potential health benefits and receiving recognition as a fast-growing company

Positive May 16, 2025 • 14:00 UTC GlobeNewswire Inc. • Sns Insider

Case Management Market to Reach USD 17.43 Billion by 2032, Driven by AI-Powered Workflow Automation | SNS Insider

The Case Management Market is projected to grow from $7.89 billion in 2023 to $17.43 billion by 2032, driven by the rising need for efficient workflow automation and regulatory compliance across industries.

MMS IBM PEGA case management workflow automation AI regulatory compliance

Sentiment note

Maximus is listed as a major player in the case management market, indicating its strong presence and offerings in this space.

Unknown Jun 28, 2024 • 12:32 UTC Zacks Investment Research • Vasundhara Sawalka

4 Stocks Trading Near 52-Week High That Can Climb Further

Investors target stocks that have been on a bullish run lately. Stocks like AMKR, THC, LDOS and MMS that are seeing price strength have a high chance of carrying the momentum forward.

THC AMKR MMS LDOS

Unknown Jun 27, 2024 • 15:35 UTC Zacks Investment Research • Zacks Equity Research

Here's Why Maximus (MMS) is an Attractive Pick Right Now

Commitment to shareholder returns makes Maximus (MMS) a reliable way for investors to compound wealth over the long term.

CRAI BBSI MMS

Unknown Jun 13, 2024 • 13:40 UTC Zacks Investment Research • Zacks Equity Research

Is Maximus (MMS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MMS

Unknown Jun 13, 2024 • 13:01 UTC Zacks Investment Research • Vasundhara Sawalka

4 Stocks Trading Near 52-Week High With More Upside Potential

Investors target stocks that have lately been on a bull run. Stocks like LPX, MMS, THC and AMKR are seeing price strength and have a high chance of carrying the momentum forward.

THC LPX AMKR MMS

Unknown Jun 7, 2024 • 15:30 UTC Zacks Investment Research • Zacks Equity Research

Maximus (MMS) Up 2.9% Since Last Earnings Report: Can It Continue?

Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MMS

Unknown Jun 3, 2024 • 12:23 UTC Zacks Investment Research • Zacks Equity Research

Maximus and Diodes have been highlighted as Zacks Bull and Bear of the Day

Maximus and Diodes are part of the Zacks Bull and Bear of the Day article.

NVDA MMS GOOGL NTNX

Unknown Jun 3, 2024 • 08:00 UTC Zacks Investment Research • Shaun Pruitt

Bull of the Day: Maximus (MMS)

Benefiting from a strong business industry, it's hard to overlook the very favorable trading indicators for Maximus (MMS) stock with MMS commanding an overall "A" VGM Zacks Style Scores Grade for the combination of Value, Growth, and Momentum.

MMS

Unknown May 30, 2024 • 16:00 UTC Zacks Investment Research • Zacks Equity Research

Maximus (MMS) Upgraded to Strong Buy: Here's What You Should Know

Maximus (MMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MMS

Unknown May 30, 2024 • 14:00 UTC Zacks Investment Research • Zacks Equity Research

Best Momentum Stocks to Buy for May 30th

IHG, MMS and GOLD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 30, 2023.

IHG GOLD MMS